Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
RenovoRx, Inc. (NASDAQ: RNXT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative precision oncology therapies designed to improve outcomes for patients with difficult-to-treat solid tumors. Their proprietary RenovoTAMP™ (Renovo catheter and Trans-Arterial Micro-Perfusion) therapy platform aims to deliver chemotherapy in a targeted manner directly to tumors, potentially increasing efficacy while minimizing systemic side effects. RenovoRx's lead drug candidate, RenĺŻłę˝ (RenovoGem™), is currently being investigated in a Phase III clinical trial (TIGeR-PaC) for the treatment of locally advanced pancreatic cancer.
The Mountain View headquarters serves as the central hub for RenovoRx's corporate operations, research and development activities, clinical trial management, and strategic planning for its oncology therapies.
The facility is situated in a modern office park and likely equipped with specialized laboratory and office spaces necessary for biopharmaceutical research, development, and administrative functions.
RenovoRx likely fosters a work culture centered on innovation, scientific excellence, collaboration, and a strong commitment to improving patient outcomes in oncology. Employees are typically mission-driven, working in a dynamic environment focused on advancing cancer treatment.
Its location in Silicon Valley provides RenovoRx with access to a rich talent pool, cutting-edge research institutions, potential collaborators, and a vibrant investment community, crucial for a clinical-stage biopharmaceutical company.
RenovoRx is primarily focused on conducting clinical trials and operations within the United States. While their therapies, if successful, could have global implications, current direct global office presence is not a primary feature. Expansion may occur through partnerships or as their products achieve regulatory approvals in different regions.
201 San Antonio Circle, Suite 115
Mountain View
CA
USA
Address: N/A
Focus is maintained on the primary R&D and corporate functions at the main headquarters.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, RenovoRx' leadership includes:
RenovoRx has been backed by several prominent investors over the years, including:
Over the last 12-18 months, RenovoRx has notably strengthened its executive team with key appointments in scientific and financial leadership to support its clinical development and corporate strategy, including a new CSO and CFO.
Discover the tools RenovoRx uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While RenovoRx does not publicly disclose its official email format, common patterns for companies of its structure often include [first_initial][last]@[companydomain].com or [first].[last]@[companydomain].com.
[first_initial][last]@renovorx.com
Format
sbagai@renovorx.com (example based on CEO Shaun Bagai)
Example
75%
Success rate
GlobeNewswire • May 7, 2024
RenovoRx announced that an abstract highlighting updated interim analysis from its Phase III TIGeR-PaC clinical trial has been accepted for poster presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting....more
GlobeNewswire • February 21, 2024
RenovoRx announced a peer-reviewed publication in the journal Pharmaceutics, detailing the proposed mechanism of action for its proprietary RenovoTAMP (Renovo catheter and Trans-Arterial Micro-Perfusion) therapy platform....more
GlobeNewswire • January 8, 2024
RenovoRx provided a business update, including progress on its Phase III TIGeR-PaC clinical trial for locally advanced pancreatic cancer and outlined key anticipated milestones for 2024....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including RenovoRx, are just a search away.